Abstract
Background: Low lymphatic tumor burden is associated with a better prognosis. However, it is uncertain whether those patients diagnosed as cN0 found to be pN+ could be a favorable subgroup in stage III disease. Radical surgery alone might avoid overtreatment in those patients. Methods: Eligible patients diagnosed with colon cancer without metastasis were recruited from the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2016 using SEER*Stat 8.3.5 software (Surveillance Research Program, National Cancer Institute) and divided into two groups: surgery group (n = 3,081) and surgery followed by adjuvant chemotherapy group (n = 4,591). Overall survival (OS) and cause-specific survival (CSS) differences were assessed by Kaplan-Meier analysis, and survival differences were estimated with log-rank tests. Univariate and multivariate Cox proportional hazard regressions were used to assess hazard ratios (HRs) and 95% confidence intervals (CIs) for colon cancer patients. Results: A total of 7,672 pT1-3N1a colon cancer patients were recruited from 208,751 colon cancer patients. The 5-year CSS rates of patients without and with adjuvant chemotherapy were 80.0 and 90.7%, respectively. The receipt of adjuvant chemother...Continue Reading
References
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Oct 25, 2001·The Oncologist·E A CalhounC L Bennett
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T E Le VoyerD G Haller
Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Al B BensonDaniel G Haller
Oct 7, 2004·Journal of the National Cancer Institute·Jessica B O'ConnellClifford Y Ko
Mar 22, 2007·Journal of the National Cancer Institute·George J ChangVirginia A Moyer
Dec 18, 2007·Lancet·UNKNOWN Quasar Collaborative GroupDavid J Kerr
May 20, 2009·Cancer·Alessia Bhargava, Xianglin L Du
Sep 10, 2009·Oncology·Edward ChuThomas Cartwright
Dec 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard L GundersonAndrew K Stewart
Aug 3, 2011·Breast Cancer Research and Treatment·A M BrewsterR L Theriault
Dec 20, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·Y HashiguchiK Sugihara
May 11, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Dejana BraithwaiteBette J Caan
Jul 3, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Roser VelascoHaralabos P Kalofonos
Jun 3, 2014·World Journal of Surgical Oncology·Jo TashiroIsamu Koyama
Oct 22, 2014·Cancer·Aalok KumarWinson Y Cheung
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Oct 22, 2016·AJR. American Journal of Roentgenology·Elias NeradRegina G H Beets-Tan
Nov 1, 2016·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Nouf AkeelFeza H Remzi
Mar 28, 2017·Clinical Oncology : a Journal of the Royal College of Radiologists·B M MeyersD Jonker
May 22, 2017·Breast Cancer Research and Treatment·Melissa J EdwardsMarion J Kuper-Hommel
Mar 29, 2018·The New England Journal of Medicine·Axel GrotheyTimothy Iveson
Apr 27, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ofer MargalitBen Boursi
Sep 13, 2018·CA: a Cancer Journal for Clinicians·Freddie BrayAhmedin Jemal
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 1, 2019·Frontiers in Oncology·Qi LiuXinxiang Li